OK Biotech Co (TPE:4155) Ending Cash Position: NT$370 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:4155 OK Biotech Co Ltd TPE:4155
72 GF Score
Price NT$14.85
GF Value NT$19.90
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is OK Biotech Co Ending Cash Position?

OK Biotech Co TPE:4155 +1.37% 72 Ending Cash Position is NT$370 Mil as of Jun. 2026. GuruFocus rates TPE:4155 with a GF Score™ of 72/100 and a GF Value™ of NT$19.90 (Modestly Undervalued). The stock has 5 warning signs investors should review.

OK Biotech Co's Ending Cash Position for the quarter that ended in Jun. 2026 was NT$370 Mil.

OK Biotech Co's quarterly Ending Cash Position declined from Dec. 2025 (NT$314 Mil) to Mar. 2026 (NT$306 Mil) but then increased from Mar. 2026 (NT$306 Mil) to Jun. 2026 (NT$370 Mil).

OK Biotech Co's annual Ending Cash Position declined from Dec. 2023 (NT$323 Mil) to Dec. 2024 (NT$277 Mil) but then increased from Dec. 2024 (NT$277 Mil) to Dec. 2025 (NT$314 Mil).

OK Biotech Co Ending Cash Position Related Terms

OK Biotech Co Ending Cash Position Historical Data

* Premium members only.

The historical data trend for OK Biotech Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OK Biotech Co Ending Cash Position Chart

OK Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 599.85 596.42 323.03 277.46 314.47

OK Biotech Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 166.19 303.48 314.47 305.79 370.14
TPE:4155
72GF Score
OK Biotech Co Ltd TPE:4155
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OK Biotech Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

OK Biotech Co's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=277.458+37.015
=314

OK Biotech Co's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=305.794+64.342
=370

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of NT$370 Mil mean?
OK Biotech Co (TPE:4155) has a Ending Cash Position of NT$370 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on OK Biotech Co and its competitors.
Is OK Biotech Co's Ending Cash Position too high?
OK Biotech Co's current Ending Cash Position is NT$370 Mil. Overall, OK Biotech Co has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does OK Biotech Co's Ending Cash Position compare to ABT and SYK?
OK Biotech Co's Ending Cash Position of NT$370 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Devices & Instruments company?
A good Ending Cash Position depends on the Medical Devices & Instruments industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on OK Biotech Co and its competitors. OK Biotech Co's current Ending Cash Position is NT$370 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OK Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, OK Biotech Co (TPE:4155) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$19.90, compared to a current price of NT$14.85 — trading 25.4% below its estimated fair value. The current Ending Cash Position is NT$370 Mil. OK Biotech Co's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For OK Biotech Co (TPE:4155), the current Ending Cash Position is NT$370 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OK Biotech Co (TPE:4155) Overvalued in 2026?

Based on GuruFocus' analysis, OK Biotech Co stock appears to be undervalued. The current stock price of NT$14.85 is trading 25.4% below its estimated GF Value™ of NT$19.90. GuruFocus considers OK Biotech Co to be Modestly Undervalued.

Key valuation signals for TPE:4155:

  • Ending Cash Position: NT$370 Mil
  • GF Value™: NT$19.90 vs. price of NT$14.85 (25.4% below fair value)
  • GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the TPE:4155 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OK Biotech Co Business Description

Address Gongdao 5th Road, Section 2, No. 91, Hsinchu, TWN, 30070
OK Biotech Co Ltd is mainly engaged in the manufacturing, wholesale, and retail of electronic materials and medical equipment. Its product portfolio comprises blood glucose monitoring systems, OTC hearing aids, multi-frequency therapy devices, and others. Geographically, the company generates the majority of its revenue from America, and the rest from Asia (excluding Taiwan), Africa, Europe, and Taiwan.
72GF Score

Get the complete analysis for TPE:4155

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$14.85
Price
NT$19.90
GF Value